Open Access
Issue
OCL
Volume 21, Number 3, May-June 2014
Article Number D302
Number of page(s) 7
Section Dossier: Vitamin D, vitamin or hormone? / La vitamine D, vitamine ou hormone ?
DOI https://doi.org/10.1051/ocl/2014001
Published online 29 April 2014
  • Abboud M, Gordon-Thomson C, Hoy AJ, et al. 2013. Uptake of 25-hydroxyvitamin D by muscle and fat cells. J. Steroid. Biochem. Mol. Biol. DOI: 10.1016/j.joGmb.2013.10.020.
  • Abboud M, Puglisi DA, Davies BN, et al. 2013. Evidence for a specific uptake and retention mechanism for 25-hydroxyvitamin D (25OHD) in skeletal muscle cells. Endocrinology 154: 3022–3030. [CrossRef] [PubMed]
  • AFSSA. 2009. Étude Individuelle Nationale des Consommations Alimentaires 2 (INCA 2) 2006–2007.
  • Alshahrani F, Aljohani N. 2013. Vitamin D: deficiency, sufficiency and toxicity. Nutrients 5: 3605–3616. [CrossRef] [PubMed]
  • Bouillon R, Carmeliet G, Verlinden L, et al. 2008. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 29: 726–776. [CrossRef] [PubMed]
  • Carlberg C, Seuter S. 2009. A genomic perspective on vitamin D signaling. Anticancer Res. 29: 3485–3493. [PubMed]
  • Castetbon K, Vernay M, Malon A, et al. 2009. Dietary intake, physical activity and nutritional status in adults: the French nutrition and health survey (ENNS, 2006–2007). Br. J. Nutr. 102: 733–743. [CrossRef] [PubMed]
  • Chen J, Doroudi M, Cheung J, et al. 2013. Plasma membrane Pdia3 and VDR interact to elicit rapid responses to 1alpha,25(OH)(2)D(3). Cell Signal 25: 2362–2373. [CrossRef] [PubMed]
  • Drincic AT, Armas LA, Van Diest EE, et al. 2012. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring) 20: 1444–1448. [CrossRef] [PubMed]
  • Dusso AS, Brown AJ, Slatopolsky E. 2005. Vitamin D. Am. J. Physiol. Renal Physiol. 289: F8–28.
  • Fu B, Wang H, Wang J, et al. 2013. Epigenetic regulation of BMP2 by 1,25-dihydroxyvitamin D3 through DNA methylation and histone modification. PLoS One 8: e61423. [CrossRef] [PubMed]
  • Gacad MA, Chen H, Arbelle JE, et al. 1997. Functional characterization and purification of an intracellular vitamin D-binding protein in vitamin D-resistant new world primate cells. Amino acid sequence homology with proteins in the hsp-70 family. J. Biol. Chem. 272: 8433–8440. [CrossRef] [PubMed]
  • Girgis CM, Clifton-Bligh RJ, Hamrick MW, et al. 2013. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr. Rev. 34: 33–83. [CrossRef] [PubMed]
  • GNS. 2012. New reference values for vitamin D. Ann. Nutr. Metab 60: 241–246.
  • Haddad JG, Matsuoka LY, Hollis BW, et al. 1993. Human plasma transport of vitamin D after its endogenous synthesis. J. Clin. Invest. 91: 2552–2555. [CrossRef] [PubMed]
  • Heaney RP, Armas LA, French C. 2013. All-source Basal vitamin d inputs are greater than previously thought and cutaneous inputs are smaller. J. Nutr. 143: 571–575. [CrossRef] [PubMed]
  • Heaney RP, Horst RL, Cullen DM, et al. 2009. Vitamin D3 distribution and status in the body. J. Am. Coll. Nutr. 28: 252–256. [CrossRef] [PubMed]
  • Holick MF. 2007. Vitamin D deficiency. N. Engl. J. Med. 357: 266–281. [CrossRef] [PubMed]
  • Holick MF, Chen TC. 2008. Vitamin D deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr. 87: 1080S–1086S. [PubMed]
  • Karlic H, Varga F. 2013. Impact of vitamin D metabolism on clinical epigenetics. Clin. Epigenetics 2: 55–61. [CrossRef]
  • Landrier JF, Marcotorchino J, Tourniaire F. 2012. Lipophilic micronutrients and adipose tissue biology. Nutrients 4: 1622–1649. [CrossRef] [PubMed]
  • Lisse TS, Adams JS, Hewison M. 2013. Vitamin D and microRNAs in bone. Crit. Rev. Eukaryot. Gene Expr. 23: 195–214. [CrossRef] [PubMed]
  • Martin A. 2001. The “apports nutritionnels conseilles (ANC)” for the French population. Reprod. Nutr. Dev. 41: 119–128. [CrossRef] [EDP Sciences] [PubMed]
  • Nemere I, Garbi N, Hammerling GJ, et al. 2010. Intestinal cell calcium uptake and the targeted knockout of the 1,25D3-MARRS (membrane-associated, rapid response steroid-binding) receptor/PDIA3/Erp57. J. Biol. Chem. 285: 31859–31866. [CrossRef] [PubMed]
  • Nykjaer A, Dragun D, Walther D, et al. 1999. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96: 507–515. [CrossRef] [PubMed]
  • Ovesen L, Brot C, Jakobsen J. 2003. Food contents and biological activity of 25-hydroxyvitamin D: a vitamin D metabolite to be reckoned with? Ann. Nutr. Metab. 47: 107–113. [CrossRef] [PubMed]
  • Reboul E, Goncalves A, Comera C, et al. 2011. Vitamin D intestinal absorption is not a simple passive diffusion: evidences for involvement of cholesterol transporters. Mol. Nutr. Food Res. 55: 691–702. [CrossRef] [PubMed]
  • Rosen CJ, Adams JS, Bikle DD, et al. 2012. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr. Rev. 33: 456–592. [CrossRef] [PubMed]
  • Ross AC, Manson JE, Abrams SA, et al. 2011. The 2011 Dietary Reference Intakes for Calcium and Vitamin D: what dietetics practitioners need to know. J. Am. Diet. Assoc. 111: 524–527. [CrossRef] [PubMed]
  • Safadi FF, Thornton P, Magiera H, et al. 1999. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J. Clin. Invest. 103: 239–251. [CrossRef] [PubMed]
  • Schmid A, Walther B. 2013. Natural vitamin d content in animal products. Adv. Nutr. 4: 453–462. [CrossRef] [PubMed]
  • Schuster I. 2011. Cytochromes P450 are essential players in the vitamin D signaling system. Biochim. Biophys. Acta. 1814: 186–199. [CrossRef] [PubMed]
  • Souberbielle JC, Friedlander G, Kahan A, et al. 2006. Evaluating vitamin D status. Implications for preventing and managing osteoporosis and other chronic diseases. Joint Bone Spine 73: 249–253. [CrossRef] [PubMed]
  • Speeckaert M, Huang G, Delanghe JR, et al. 2006. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin. Chim. Acta. 372: 33–42. [CrossRef] [PubMed]
  • Turano C, Gaucci E, Grillo C, et al. 2011. ERp57/GRP58: a protein with multiple functions. Cell. Mol. Biol. Lett. 16: 539–563. [CrossRef] [PubMed]
  • Vieth R. 1999. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am. J. Clin. Nutr. 69: 842–856. [PubMed]
  • Zhou C, Assem M, Tay JC, et al. 2006. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J. Clin. Invest. 116: 1703–1712. [CrossRef] [PubMed]